Skip to content
10-K/A

Annual Report

THERABIOGEN, INC.

0001393905-12-000384

← back to feed
Filed
Jul 18, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Feb 29, 2012 61.06M sh
Operating Cash Flow restated FY 2011 · Feb 29, 2012 −$1.22M
Operating Cash Flow FY 2011 · Feb 28, 2011 −$1.33M
Cash And Equivalents FY 2011 · Feb 29, 2012 $290
Cash And Equivalents FY 2011 · Feb 28, 2010 $4.14K
Stockholders Equity FY 2011 · Feb 29, 2012 $35.72K
Stockholders Equity FY 2011 · Feb 28, 2011 $1.02M
Current Liabilities FY 2011 · Feb 29, 2012 $2.69M
Current Liabilities FY 2011 · Feb 28, 2011 $1.47M
Total Liabilities FY 2011 · Feb 29, 2012 $2.69M
Total Liabilities FY 2011 · Feb 28, 2011 $1.61M
Current Assets FY 2011 · Feb 29, 2012 $470K
Current Assets FY 2011 · Feb 28, 2011 $352.13K
Total Assets FY 2011 · Feb 29, 2012 $2.73M
Total Assets FY 2011 · Feb 28, 2011 $2.63M
Sga Expense restated FY 2011 · Feb 29, 2012 $13.44M
Sga Expense FY 2011 · Feb 28, 2011 $3.58M
Net Income FY 2011 · Feb 29, 2012 −$16.16M
Net Income FY 2011 · Feb 28, 2011 −$4.09M
Cost Of Revenue FY 2011 · Feb 29, 2012 $782.23K
Cost Of Revenue FY 2011 · Feb 28, 2011 $488.62K
Revenue FY 2011 · Feb 29, 2012 $950.8K
Revenue FY 2011 · Feb 28, 2011 $466.32K